Download PDF
Thromb Haemost 1982; 48(03): 289-293
DOI: 10.1055/s-0038-1657283
Original Article
Schattauer GmbH Stuttgart

Tests for Platelet Changes, Acute Phase Reactants and Serum Lipids in Diabetes mellitus and Peripheral Vascular Disease

B A van Oost
The Department of Haematology, University Hospital Utrecht, Utrecht, The Netherlands
,
B F E Veldhuyzen
The Department of Haematology, University Hospital Utrecht, Utrecht, The Netherlands
,
H C van Houwelingen
*   Department of Mathematical Statistics, State University, Utrecht, The Netherlands
,
A P M Timmermans
The Department of Haematology, University Hospital Utrecht, Utrecht, The Netherlands
,
J J Sixma
The Department of Haematology, University Hospital Utrecht, Utrecht, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 14 May 1982

Accepted 13 October 1982

Publication Date:
13 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Platelets tests, acute phase reactants and serum lipids were measured in patients with diabetes mellitus and patients with peripheral vascular disease. Patients frequently had abnormal platelet tests and significantly increased acute phase reactants and serum lipids, compared to young healthy control subjects. These differences were compared with multidiscriminant analysis. Patients could be separated in part from the control subjects with variables derived from the measurement of acute phase proteins and serum lipids. Platelet test results improved the separation between diabetics and control subjects, but not between patients with peripheral vascular disease and control subjects. Diabetic patients with severe retinopathy frequently had evidence of platelet activation. They also had increased acute phase reactants and serum lipids compared to diabetics with absent or nonproliferative retinopathy. In patients with peripheral vascular disease, only the fibrinogen concentration was related to the degree of vessel damage by arteriography.

Keywords

Diabetes mellitus - Peripheral vascular disease - Platelet density - β-thromboglobulin
 

  • References

  • 1 Baumgartner HR, Muggli R. In: Platelets in Biology and Pathology. Gordon JL. Elsevier; Amsterdam: 1976: 23-60
  • 2 Ross R, Glomset J, Kariya B, Harker LA. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vivo. Proc Natl Acad Sci 1974; 71: 1207-1211
    CrossrefPubMedGoogle Scholar
  • 3 Goldberg ID, Stemerman MB, Handin RI. Vacular Permeation of Platelet Factor 4 after endothelial injury. Science 1980; 209: 611-612
    CrossrefPubMedGoogle Scholar
  • 4 Friedman RJ, Stemerman MB, Wenz B, Moore S, Gouldie J, Gent M, Tiell ML, Spaet TH. The effect of Thrombocytopenia on Experimental Arteriosclerotic Lesion Formation in Rabbits. J Clin Invest 1977; 60: 1191-1201
    CrossrefPubMedGoogle Scholar
  • 5 Buchanan MR, Carter CJ, Hirsch J. Decreased Platelet Thrombogenicity in Association with Increased Platelet Turnover and Vascular Damage. Blood 1979; 54: 1369-1375
    PubMedGoogle Scholar
  • 6 Harker LA, Hanson SR. Experimental Arterial Thromboembolism in Baboons. J Clin Invest 1979; 64: 559-569
    CrossrefPubMedGoogle Scholar
  • 7 Goldsmith HL. The Flow of Model Particles and Blood Cells and its relation to Thrombogenesis. In: Progress in Haemostasis and Thrombosis. Spaet TH. (ed.). vol 1 Grune & Stratton; New York: 1972: 79-139
    Google Scholar
  • 8 van Oost BA, van Hien-Hagg IH, Veldhuyzen BFE, Timmermans APM, Sixma JJ. Determination of the density distribution of human platelets. Thromb Haemostas 1982; 47: 239-243
    PubMedGoogle Scholar
  • 9 Wu KK, Hoak JC. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; 2: 924-926
    PubMedGoogle Scholar
  • 10 Mielke CH, Kaneshiro MM, Maher LA, Weiner JM, Rapaport SI. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969; 34: 204-215
    PubMedGoogle Scholar
  • 11 Bouma BN. A modification of the immunochemical determination of split products described by Nilehn. Scand J Haematol 1971; 13 suppl 391-392
    PubMedGoogle Scholar
  • 12 Over J, Bouma BN, van Mourik JA, Sixma JJ, Vlooswijk RAA, Bakker-Woudenberg I. Heterogeneity of human factor VIII. I. Characterization of factor VIII present in the supernatant of cryopre-cipitate. J Lab Clin Med 1978; 91: 32-46
    PubMedGoogle Scholar
  • 13 Snedecor GW, Cochran WG. Statistical Methods. Iowa State University Press; Ames, Iowa: 6. 1967
    Google Scholar
  • 14 Anderson TW. An introduction to Multivariate Statistical Analysis. J. Wiley & Sons; New York: 1958
    Google Scholar
  • 15 Garg SK, Lackner H, Karpatkin S. The increased Percentage of Megathrombocytes in Various Clinical Disorders. Ann Int Med 1972; 77: 361-369
    CrossrefPubMedGoogle Scholar
  • 16 Colwell JA, Sagel J, Crook L, Chambers A, Laimins M. Correlation of Platelet Aggregation. Plasma Factor Activity and Megathrombocytes in Diabetic Subjects with and without Vascular Disease. Metabolism 1977; 26: 279-285
    CrossrefPubMedGoogle Scholar
  • 17 Colwell JA, Halushka PV. Platelet Function in diabetes mellitus. Br J Haematol 1980; 44: 521-526
    CrossrefPubMedGoogle Scholar
  • 18 Tindall H, Paton RC, Zuzel M, McNicol GP. Platelet life-span in diabetics with and without retinopathy. Thromb Res 1981; 21: 641-648
    CrossrefPubMedGoogle Scholar
  • 19 Mustard JF, Packham MA. Platelets and diabetes mellitus. N Engl J Med 1977; 297: 1345-1347
    CrossrefPubMedGoogle Scholar
  • 20 Colwell JA, Halushka PV, Sarji K, Levine J, Sagel J, Nair RMG. Altered Platelet Function in Diabetes mellitus. Diabetes 1976; 25: 826-831
    PubMedGoogle Scholar
  • 21 Kwaan HC, Colwell JA, Cruz S, Suwanwela N, Dobbie JG. Increased platelet aggregation in diabetes mellitus. J Lab Clin Med 1972; 80: 236-246
    PubMedGoogle Scholar
  • 22 Bensoussan D, Levy-Toledano S, Passa P, Caen J, Canicet J. Platelet Hyperaggregation and Increased Plasma Level of Von Willebrand Factor in Diabetics with Retinopathy. Diabetologica 1975; 11: 307-312
    CrossrefPubMedGoogle Scholar
  • 23 Halushka PV, Larie D, Colwell JA. Increased synthesis of prostag-landin-E-like in material by platelets from patients with diabetes mellitus. N Eng J Med 1977; 297: 1306-1310
    CrossrefPubMedGoogle Scholar
  • 24 Halushka PV, Rogers RC, Loadholt CB, Colwell JA. Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med 1981; 97: 87-96
    PubMedGoogle Scholar
  • 25 Lagarde M, Burtin M, Berciaud P, Blanc M, Velardo B, Dechavanne M. Increase of platelet thromboxane A2 formation of its plasmatic half-life in diabetes mellitus. Thromb Res 1980; 19: 823-830
    CrossrefPubMedGoogle Scholar
  • 26 Rendu F, Nurden AT, Lebret M, Caen JP. Relationship between Mepacrine-Labelled Dense Body Number, Platelet Capacity to Accumulate 14C-5-HT and Platelet Density in the Bemard-Soulier and Hermansky Pudlak Syndromes. Thromb Haemostas 1979; 42: 694-704
    PubMedGoogle Scholar
  • 27 Celia G, Zahavi J, de Haas HA, Kakkar VV. β-Thromboglobulin, Platelet Production Time and Platelet Function in Vascular Disease. Br J Haematol 1979; 43: 127-136
    CrossrefPubMedGoogle Scholar
  • 28 Boughton BJ, Allington MJ, King A. Platelet and Plasma β-thromboglobulin in Myeloproliferative Syndromes and Secondary Thrombocytosis. Br J Haematol 1978; 40: 125-132
    CrossrefPubMedGoogle Scholar
  • 29 Bolton AE, Amess JAL, Lekhwani CP, Elliott P. β-Thromboglobulin Content of Human Blood Platelets. Scand J Haematol 1980; 25: 25-29
    PubMedGoogle Scholar
  • 30 O’Brien JR, Etherington MD. An Inverse Relation between Platelet Factor 4 in the Platelet and in the Plasma. Thromb Haemostas 1976; 36: 649-651
    PubMedGoogle Scholar
  • 31 O’Brien JR. “Exhausted” platelets continue to circulate. The Lancet 1978; 2: 1316-1317
    PubMedGoogle Scholar
  • 32 Dormandy JA, Hoare E, Colley J, Arrowsmith DE, Dormandy TL. Clinical, Haemodynamic, Rheological and Biochemical Findings in 126 Patients with Intermittent Claudication. Br Med J 1973; 4: 576-581
    CrossrefPubMedGoogle Scholar
  • 33 Dormandy JA, Hoare E, Khattab AH, Arrowsmith DE, Dormandy TL. Prognostic Significance of Rheological and Biochemical Findings in Patients with intermittent Claudication. Br Med J 1973; 2: 581-583
    PubMedGoogle Scholar
  • 34 Fuller JH, Keen H, Jarret RJ, Omer T, Meade TW, Chakrabarti R, North WRS, Stirling Y. Haemostatic variables associated with diabetes and its complication. Br J Med 1979; 2: 964-966
    CrossrefPubMedGoogle Scholar
  • 35 Coller BS, Frank RN, Milton RC, Gralnick HR. Plasma Cofactors of Platelet Function: Correlation with Diabetic Retinopathy and Hemoglobins A1a-c . Ann Int Med 1978; 88: 311-316
    CrossrefPubMedGoogle Scholar
  • 36 Jones RL, Peterson CM. Reduced Fibrinogen Survival in Diabetes Mellitus. J Clin Invest 1979; 63: 485-493
    CrossrefPubMedGoogle Scholar
  • 37 Bern MM, Cassani MP, Horton J, Rand L, Davis G. Changes in fibrinolysis and factor VIII coagulant, antigen, and ristocetin cofactor in diabetes mellitus and atherosclerosis. Thromb Res 1980; 19: 831-839
    CrossrefPubMedGoogle Scholar
  • 38 Boneu B, Sie P, Caranobe C, Lefebvre D, Pradere B, Bastide G. Platelet Density, 5 HT Organelles and Production Time in Chronic Artritis of the Lower Limbs. Thromb Haemostas 1980; 44: 167
    PubMedGoogle Scholar
  • 39 Gensini GF, Abbate R, Favilla S, Neri Serneri GG. Changes of Platelet Function and Blood Clottting in Diabetes mellitus. Thromb Haemostas 1979; 42: 983-993
    PubMedGoogle Scholar
  • 40 Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1979; 1: 153-156
    CrossrefPubMedGoogle Scholar
  • 41 Meade TW, North WRS, Chakrabarti R, Stirling Y, Haines AP, Thompson SG. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980; 1: 1050-1053
    PubMedGoogle Scholar
  • 42 Levy RI. Cholesterol, Lipoproteins, Apoproteins, and Heart Disease: Present Status and Future Prospects. Clin Chem 1981; 27: 635-662
    PubMedGoogle Scholar
  • 43 White GC, Marouf AA. Platelet factor 4 levels in patients with coronary artery disease. J Lab Clin Med 1981; 97: 369-377
    PubMedGoogle Scholar
  • 44 Cambell IW, Dawes J, Frazer DM, Pepper DS, Clarke BF, Duncan LJP, Cash JD. Plasma β-Thromboglobulin in Diabetes mellitus. Diabetes 1977; 26: 1175-1177
    CrossrefPubMedGoogle Scholar
  • 45 Burrows AW, Chavin SI, Hockaday TDR. Plasma-thromboglobulin concentrations in diabetes mellitus. Lancet 1978; 1: 235-237
    PubMedGoogle Scholar
  • 46 Borsey DQ, Dawes J, Frazer DM, Prowse CV, Elton RA, Clarke BF. Plasma Beta-thromboglobulin in Diabetes mellitus. Diabetologica 1980; 18: 353-357
    PubMedGoogle Scholar
  • 47 Preston FE, Ward JD, Marcola BH, Porter NR, Timperley WR, O’Malley BC. Elevated β-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Lancet 1978; 1: 238-239
    PubMedGoogle Scholar
  • 48 Matthews JH, O’Connor JF, Hearnshaw JR, Wood JK. Beta-Thromboglobulin and Glycosylated Haemoglobin in Diabetes mellitus. Scand J Haematol 1979; 23: 421-426
    PubMedGoogle Scholar
  • 49 Depperman D, Andrassy K, Seelig H, Ritz E, Post D. Beta-Thromboglobulin is elevated in renal failure without thrombosis. Thromb Res 1980; 17: 63-69
    CrossrefPubMedGoogle Scholar
  • 50 Kaplan KL, Owen J. Plasma Levels of β-Thromboglobulin and Platelet Factor 4 as Indices of Platelet Activation in Vivo. Blood 1981; 57: 199-202
    PubMedGoogle Scholar
  • 51 O’Malley BC, Timperley WR, Ward JD, Porter NR, Preston FE. Platelet Abnormalities in diabetic peripheral neuropathy. Lancet 1975; 2: 1274-1276
    PubMedGoogle Scholar